AI주식인사이트AI Stock Insight
B

프롬바이오

377220KOSDAQ

62.1 / 100

Reference Date: 2026-09-08

Financial Score18.5 / 40
News Sentiment20.6 / 25
Momentum13.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 472.1% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

PromBIO is a comprehensive health functional food company operating the entire value chain, leveraging its ownership of individually certified functional ingredients and R&D capabilities to establish a strong market position. Focusing on its flagship Boswellia and Mastica product lines, the company is expanding into cosmetics and new areas such as cell culture and stem cell research.

Number of Employees

147people

Average Salary

37.9M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
0.64Industry Average 1.205.5Point

Lower than industry avg (good)

ROE
-61.68Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
7.75Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20251.0 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲4.0% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼17.0% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -39.4% (declining, 3yr)

Detailed News Sentiment

10 totalPositive 9Neutral 1Negative 0Average Sentiment Score 82.5

Detailed Momentum

52-week position6.0Point

52w upper range (76%)

Current 2,935Won52-week high 3,68552-week low 513
1-month return6.0Point

1m +472.12% (strong rise)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-19
  • Neutral주식등의대량보유상황보고서(일반)2026-08-19
  • Neutral반기보고서 (2026.06)2026-08-14